The top additions for MFs in October were Dr Reddy’s, D Mart, and Bharti Airtel. At the same time, Infosys, HUL, and HDFC Bank were major reductions in portfolios.

The sector remains underweight on banking and financial stocks, reducing positions in HDFC Bank (Rs 1,073 crore), HDFC Ltd (Rs 895 crore), and Axis Bank (Rs 647 crore), while minor additions were also seen in SBI (Rs 200 crore) and Kotak Mahindra Bank (Rs 133 crore). Banking and financial stocks have run up this month, with the NSE Bankex up 9.5 per cent.

Funds trimmed positions in FMCG stocks, too, such as Hindustan Uni­lever (Rs 1,314 crore), ITC (Rs 967 crore), Asian Paints (Rs 330 crore), and Nestlé (Rs 280 crore), along with IT firms Inf­o­sys (Rs 1,480 crore), TCS (Rs 429 crore), and Mindtree (Rs 230 crore). Ma­rginal additions were seen in Coforge (Rs 283 crore), HCL Tech (Rs 235 crore), and Oracle Financial (Rs 235 crore).

Fund houses added pharma counters such as Dr Reddy’s (Rs 750 crore), Sun Pharma (Rs 300 crore), Lupin (Rs 137 crore), and Apollo Hospital (Rs 100 crore), with some profit-booking seen in IPCA Labs (Rs 190 crore).


Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Source link
#Mutual #funds #October #report #Financial #stocks #pharmaceuticals

Leave a comment

Your email address will not be published. Required fields are marked *